Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Harvard Business School
Accenture
Citi
Cerilliant
Cipla
US Army
Covington
Julphar
Boehringer Ingelheim

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 006317

« Back to Dashboard

NDA 006317 describes SULFONAMIDES DUPLEX, which is a drug marketed by Lilly and is included in one NDA. Additional details are available on the SULFONAMIDES DUPLEX profile page.

The generic ingredient in SULFONAMIDES DUPLEX is sulfadiazine; sulfamerazine. There are seventeen drug master file entries for this compound. Additional details are available on the sulfadiazine; sulfamerazine profile page.
Summary for 006317
Tradename:SULFONAMIDES DUPLEX
Applicant:Lilly
Ingredient:sulfadiazine; sulfamerazine
Patents:0

Profile for product number 007

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION;ORALStrength250MG/5ML;250MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 011

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength167MG;167MG;167MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 012

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION;ORALStrength167MG/5ML;167MG/5ML;167MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Fish and Richardson
Fuji
Deloitte
Harvard Business School
Julphar
Cerilliant
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot